Correlation Between Microsoft and Vir Biotechnology
Can any of the company-specific risk be diversified away by investing in both Microsoft and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Vir Biotechnology, you can compare the effects of market volatilities on Microsoft and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Vir Biotechnology.
Diversification Opportunities for Microsoft and Vir Biotechnology
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Microsoft and Vir is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Microsoft i.e., Microsoft and Vir Biotechnology go up and down completely randomly.
Pair Corralation between Microsoft and Vir Biotechnology
Given the investment horizon of 90 days Microsoft is expected to generate 0.25 times more return on investment than Vir Biotechnology. However, Microsoft is 3.95 times less risky than Vir Biotechnology. It trades about -0.05 of its potential returns per unit of risk. Vir Biotechnology is currently generating about -0.03 per unit of risk. If you would invest 42,574 in Microsoft on August 27, 2024 and sell it today you would lose (874.00) from holding Microsoft or give up 2.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Microsoft vs. Vir Biotechnology
Performance |
| Timeline |
| Microsoft |
| Vir Biotechnology |
Microsoft and Vir Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and Vir Biotechnology
The main advantage of trading using opposite Microsoft and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.| Microsoft vs. GigaCloud Technology Class | Microsoft vs. Arqit Quantum | Microsoft vs. Cemtrex | Microsoft vs. Paysafe |
| Vir Biotechnology vs. CureVac NV | Vir Biotechnology vs. Krystal Biotech | Vir Biotechnology vs. Propanc Biopharma | Vir Biotechnology vs. Blueprint Medicines Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |